| 1 |
董强. 脑静脉及静脉窦血栓形成 [J]. 中华脑血管病杂志(电子版), 2009, 3(1): 43-47.
|
| 2 |
Wang L, Duan J, Bian T, et al. Inflammation is correlated with severity and outcome of cerebral venous thrombosis [J]. J Neuroinflammation, 2018, 15(1): 329.
|
| 3 |
Zuurbier SM, Arnold M, Middeldorp S, et al. Risk of cerebral venous thrombosis in obese women [J]. JAMA Neurology, 2016, 73(5): 579-584.
|
| 4 |
Samad F, Ruf W. Inflammation, obesity, and thrombosis [J]. Blood, 2013, 122(20): 3415-3422.
|
| 5 |
Freedman JE, Larson MG, Tanriverdi K, et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the framingham heart study [J]. Circulation, 2010, 122(2): 119-129.
|
| 6 |
Campia U, Tesauro M, Cardillo C. Human obesity and endothelium-dependent responsiveness [J]. Br J Pharmacol, 2012, 165(3): 561-573.
|
| 7 |
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 196: thromboembolism in pregnancy [J]. Obstet Gynecol, 2018, 132(1): e1-e17.
|
| 8 |
Amoozegar F, Ronksley PE, Sauve R, et al. Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis [J]. Front Neurol, 2015, 6: 7.
|
| 9 |
Straub RH. The complex role of estrogens in inflammation [J]. Endocr Rev, 2007, 28(5): 521-574.
|
| 10 |
Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways [J]. Cell Immunol, 2015, 294(2): 63-69.
|
| 11 |
Kim CS, Yea K, Morrell CN, et al. Estrogen activates endothelial exocytosis [J]. Biochem Biophys Res Commun, 2021, 558: 29-35.
|
| 12 |
Lu Q, Schnitzler GR, Vallaster CS, et al. Unliganded estrogen receptor alpha regulates vascular cell function and gene expression [J]. Mol Cell Endocrinol, 2017, 442: 12-23.
|
| 13 |
Zhang B, Lang Y, Zhang W, et al. Characteristics and management of autoimmune disease-associated cerebral venous sinus thrombosis [J]. Front Immunol, 2021, 12: 671101.
|
| 14 |
Emmi G, Bettiol A, Silvestri E, et al. Vascular behcet's syndrome: an update [J]. Intern Emerg Med, 2019, 14(5): 645-652.
|
| 15 |
Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance [J]. Ann Intern Med, 1990, 112(9): 682-698.
|
| 16 |
Obi AT, Andraska E, Kanthi Y, et al. Endotoxaemia-augmented murine venous thrombosis is dependent on TRL-4 and ICAM-1, and potentiated by neutropenia [J]. Thromb Haemost, 2017, 117(2): 339-348.
|
| 17 |
Hippenstiel S, Suttorp N. Interaction of pathogens with the endothelium [J]. Thromb Haemost, 2003, 89(1): 18-24.
|
| 18 |
Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms [J]. Blood, 2019, 133(9): 906-918.
|
| 19 |
Sorvillo N, Cherpokova D, Martinod K, et al. Extracellular DNA net-works with dire consequences for health [J]. Circ Res, 2019, 125(4): 470-488.
|
| 20 |
Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis [J]. Semin Thromb Hemost, 2019, 45(1): 86-93.
|
| 21 |
Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19 [J]. Blood, 2020, 136(11): 1317-1329.
|
| 22 |
Saneto RP, Sample S, Kinkel RP. Traumatic intracerebral venous thrombosis associated with an abnormal golf swing [J]. Headache, 2000, 40(7): 595-598.
|
| 23 |
Ding R, Ou W, Chen C, et al. Endoplasmic reticulum stress and oxidative stress contribute to neuronal pyroptosis caused by cerebral venous sinus thrombosis in rats: involvement of txnip/peroxynitrite-NLRP3 inflammasome activation [J]. Neurochem Int, 2020, 141: 104856.
|
| 24 |
Rashad S, Niizuma K, Sato-Maeda M, et al. Early BBB breakdown and subacute inflammasome activation and pyroptosis as a result of cerebral venous thrombosis [J]. Brain Res, 2018, 1699: 54-68.
|
| 25 |
Mu SW, Dang Y, Fan YC, et al. Effect of HMGB1 and rage on brain injury and the protective mechanism of glycyrrhizin in intracranial-sinus occlusion followed by mechanical thrombectomy recanalization [J]. Int J Mol Med, 2019, 44(3): 813-822.
|
| 26 |
Godo S, Shimokawa H. Endothelial functions [J]. Arterioscler Thromb Vasc Biol, 2017, 37(9): e108-e114.
|
| 27 |
Saito A. Emt and endmt: Regulated in similar ways? [J]. J Biochem, 2013, 153(6): 493-495.
|
| 28 |
Pilard M, Ollivier EL, Gourdou-Latyszenok V, et al. Endothelial cell phenotype, a major determinant of venous thrombo-inflammation [J]. Front Cardiovasc Med, 2022, 9: 864735.
|
| 29 |
Alarcon-Martinez L, Yemisci M, Dalkara T. Pericyte morphology and function [J]. Histol Histopathol, 2021, 36(6): 633-643.
|
| 30 |
Liu R, Lauridsen HM, Amezquita RA, et al. IL-17 promotes neutrophil-mediated immunity by activating microvascular pericytes and not endothelium [J]. J Immunol, 2016, 197(6): 2400-2408.
|
| 31 |
Miyamoto K, Heimann A, Kempski O. Microcirculatory alterations in a mongolian gerbil sinus-vein thrombosis model [J]. J Clin Neurosci, 2001, 8Suppl 1: 97-105.
|
| 32 |
Nagai M, Terao S, Yilmaz G, et al. Roles of inflammation and the activated protein c pathway in the brain edema associated with cerebral venous sinus thrombosis [J]. Stroke, 2010, 41(1): 147-152.
|
| 33 |
Jayaraj RL, Azimullah S, Beiram R, et al. Neuroinflammation: Friend and foe for ischemic stroke [J]. J Neuroinflammation, 2019, 16(1): 142.
|
| 34 |
Vieira-de-Abreu A, Campbell RA, Weyrich AS, et al. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum [J]. Semin Immunopathol, 2012, 34(1): 5-30.
|
| 35 |
Ponomaryov T, Payne H, Fabritz L, et al. Mast cells granular contents are crucial for deep vein thrombosis in mice [J]. Circ Res, 2017, 121(8): 941-950.
|
| 36 |
Carestia A, Kaufman T, Schattner M. Platelets: new bricks in the building of neutrophil extracellular traps [J]. Front Immunol, 2016, 7: 271.
|
| 37 |
Friesenecker B, Tsai AG, Intaglietta M. Cellular basis of inflammation, edema and the activity of daflon 500 mg [J]. Int J Microcirc Clin Exp, 1995, Suppl 1: 17-21.
|
| 38 |
Guo Z, Du X, Zhang Y, et al. Diosmin alleviates venous injury and muscle damage in a mouse model of iliac vein stenosis [J]. Front Cardiovasc Med, 2021, 8: 785554.
|
| 39 |
Schastlivtsev I, Lobastov K, Barinov V, et al. Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the ridilott dvt study [J]. Int Angiol, 2020, 39(5): 361-371.
|
| 40 |
Ding R, Li H, Liu Y, et al. Activating cgas-sting axis contributes to neuroinflammation in cvst mouse model and induces inflammasome activation and microglia pyroptosis [J]. J Neuroinflammation, 2022, 19(1): 137.
|
| 41 |
Nieswandt B, Kleinschnitz C, Stoll G. Ischaemic stroke: a thrombo-inflammatory disease? [J]. J Physiol, 2011, 589(17): 4115-4123.
|
| 42 |
Boulaftali Y, Hess PR, Getz TM, et al. Platelet itam signaling is critical for vascular integrity in inflammation [J]. J Clin Invest, 2013, 123(2): 908-916.
|
| 43 |
Mwiza JMN, Lee RH, Paul DS, et al. Both g protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice [J]. Blood, 2022, 139(21): 3194-3203.
|
| 44 |
Payne H, Ponomaryov T, Watson SP, et al. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis [J]. Blood, 2017, 129(14): 2013-2020.
|
| 45 |
Tam CS, Opat S, D'Sa S, et al. A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic waldenström macroglobulinemia: the aspen study [J]. Blood, 2020, 136(18): 2038-2050.
|
| 46 |
Voors-Pette C, Lebozec K, Dogterom P, et al. Safety and tolerability, pharmacokinetics, and pharmacodynamics of ACT017, an antiplatelet GPⅥ (glycoprotein Ⅵ) fab [J]. Arterioscler Thromb Vasc Biol, 2019, 39(5): 956-964.
|
| 47 |
Uncu H. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis [J]. Phlebology, 2009, 24(2): 56-60.
|